Clinical Trials on Benign Thyroid Nodule

Total 4380 results

Academic and Community Cancer Research United
National Cancer Institute (NCI)

Completed

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Poorly Differentiated Thyroid Gland Carcinoma | Recurrent Differentiated Thyroid Gland Carcinoma | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary... and other conditions

United States
National Institute of Diabetes and Digestive and...

Recruiting

Studies on Tumors of the Thyroid

Thyroid Cancer | Papillary Thyroid Cancer | Hurthle Cell Thyroid Cancer | Tall Cell Variant Thyroid Cancer | Follicular Thyroid Cancer

United States
Radboud University Medical Center

Completed

Myeloid Cell Reprogramming in Thyroid Carcinoma

Thyroid Cancer

Netherlands
Memorial Sloan Kettering Cancer Center

Active, not recruiting

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Thyroid Cancer, Follicular | Thyroid Cancer | Papillary Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid Cancer | Hurthle Cell Tumor | Hurthle Cell Thyroid Neoplasia

United States
Nanjing First Hospital, Nanjing Medical University

Recruiting

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Radiotherapy; Complications | DTC - Differentiated Thyroid Cancer | Thyroid Stimulating; Hormone, C

China
Peking Union Medical College Hospital

Recruiting

Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer

Radioactive Iodine-refractory Differentiated Thyroid Cancer

China
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident

Thyroid Cancer | Non-Cancer Thyroid Disease | Non Thyroid Cancer

Belarus
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVA Thyroid Gland...

United States
Children's Hospital of Philadelphia
United States Department of Defense

Recruiting

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Pediatric Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer

United States
National Cancer Institute (NCI)

Completed

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Recurrent Thyroid Gland Carcinoma | Stage III Thyroid Gland Papillary Carcinoma | Stage IV Thyroid Gland Papillary Carcinoma | Stage III Thyroid Gland Follicular Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma

United States
mariam hamouda

Completed

Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis

Benign Migratory Glossitis

Egypt
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Unknown

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients (Estimabl)

Thyroid Cancer

France
European Institute of Oncology

Recruiting

Minimally Invasive Treatments of the Thyroid (MIPA-MITT)

Papillary Thyroid Microcarcinoma

Italy
The New York Eye & Ear Infirmary

Terminated

DIM as a Treatment for Thyroid Disease

Proliferative Thyroid Disease

United States
National Cancer Institute (NCI)

Terminated

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Thyroid Neoplasms | Differentiated Thyroid Cancer | Poorly Differentiated and Undifferentiated Thyroid Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Refractory Differentiated Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Tall Cell Variant Thyroid Gland Papillary Carcinoma | Differentiated Thyroid Gland Carcinoma | Thyroid... and other conditions

United States
National Cancer Institute (NCI)

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Insular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Thyroid Gland Medullary Carcinoma

United States
Grupo Espanol de Tumores Neuroendocrinos
Ipsen; MFAR

Recruiting

Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. (CABOTHYROID)

Differentiated Thyroid Cancer

Spain
University College, London
National Institute for Health Research, United Kingdom

Recruiting

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers (HoT)

Differentiated Thyroid Cancer

United Kingdom
University Medical Center Groningen

Recruiting

Iodine Uptake After a Low Iodine Diet (IULID)

Differentiated Thyroid Cancer

Netherlands
University Hospital, Essen

Recruiting

Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition (ERRITI)

Metastatic Thyroid Cancer

Germany
Centre Leon Berard

Recruiting

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (LENVOS)

Thyroid Cancer Metastatic

France
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

Differentiated Thyroid Cancer

China
Peking Union Medical College Hospital

Active, not recruiting

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

China
Assiut University

Unknown

The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

Egypt
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)

Differentiated Thyroid Cancer

China
Assistance Publique - Hôpitaux de Paris

Unknown

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy (METATHYRAF)

Differentiated Thyroid Cancer

France
Newcastle-upon-Tyne Hospitals NHS Trust

Completed

Diagnosing Thyroid Cancer Using a Blood Test

Differentiated Thyroid Cancer

United Kingdom
National Institute of Diabetes and Digestive and...

Completed

Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

Thyroid Cancer | Differentiated Thyroid Carcinoma

United States
Hospital de Clinicas de Porto Alegre

Enrolling by invitation

Primary Care Transfer for Thyroid Cancer Patients

Differentiated Thyroid Cancer

Brazil
The Netherlands Cancer Institute
UMC Utrecht; Amsterdam UMC, location VUmc

Unknown

PET Evaluation of Recurrent Differentiated Thyroid Cancer (THYROPET)

Thyroid Neoplasms | Differentiated Thyroid Cancer

Netherlands
Power Life Sciences Inc.

Not yet recruiting

Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

Anaplastic Thyroid Cancer
Stanford University
Merck Sharp & Dohme LLC

Recruiting

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Thyroid Cancer

United States
Velindre NHS Trust

Recruiting

interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT) (iNATT)

Anaplastic Thyroid Cancer

Ireland, United Kingdom
Daiichi Sankyo, Inc.

Terminated

A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Anaplastic Thyroid Cancer

United States
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

High Resolution Imaging for Analysis of MVNT (HAM)

Benign Neuronal Desease

France
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor) (MIAM)

Benign Neuronal Desease

France
University of Florida

Withdrawn

Use of Metal Stents on Benign Esophageal Lesions

Benign Esophageal Lesions
Damascus University

Completed

Diagnostic Accuracy of Ultrasonography in Detecting Benign Radiolucent Lesions

Benign Radiolucent Lesions

Syrian Arab Republic
Kaohsiung Medical University Chung-Ho Memorial...
Kaohsiung Medical University

Completed

Neuromuscular Block Monitoring During Monitored Thyroidectomy

Thyroid Surgery

Taiwan
Seoul National University Hospital
SMG-SNU Boramae Medical Center

Completed

Adequate Dosage of Sugammadex on Thyroid Surgery

Thyroid Surgery

Korea, Republic of
University of Rzeszow

Completed

Iontophoresis With Potassium Iodide and Thyroid Function

Thyroid Dysfunction

Poland
University of Glasgow
NHS Greater Glasgow and Clyde

Unknown

Mothers and Babies at Yorkhill Thyroid Health Cohort (MABY)

Thyroid Function

United Kingdom
University of Arkansas

Completed

Thyroid Dysfunction in Head and Neck Surgery Patients

Thyroid Dysfunction

United States
University Health Network, Toronto
University of British Columbia; Canadian Institutes of Health Research (CIHR); CHU de Quebec-Universite Laval and other collaborators

Recruiting

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Papillary Thyroid Carcinoma | Papillary Thyroid Cancer | Papillary Microcarcinoma of the Thyroid

Canada
Dana-Farber Cancer Institute
Millennium Pharmaceuticals, Inc.

Completed

A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer

Thyroid Cancer | Differentiated Thyroid Cancer | Anaplastic Thyroid Cancer

United States
Leiden University Medical Center

Completed

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

Thyroid Cancer

Netherlands
Fudan University

Recruiting

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Thyroid | Thyroid Cancer | Refractory Thyroid Cancer

United States

Clinical Trials on Benign Thyroid Nodule

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations